摘要:
The present invention relates to novel compounds selected from substituted oxazole derivatives of formula (I) that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit, bcr-abl and Flt-3 inhibitors.
摘要:
The present invention relates to an in vitro method for determining the prognosis of pancreatic cancer in a patient. More particularly, this method comprises the following steps: c) measuring the expression level of at least two genes chosen in the group consisting in: ING5, RUNDC1, ABCC1, FGFR3, S100A6, ANKRD55, and CD8A or homologous genes, in a blood sample of said patient, d) predicting the outcome of the pancreatic cancer in said patient. The invention also relates to a kit specifically designed to carry out such a method.
摘要:
The present invention relates to compounds of general formula (I).
wherein A represents an optionally substituted heterocyclyl group, B represents an aryl or heteroaryl group and wherein X, R1, R2, R3, R4 and R5 are as defined in the description. Compounds of formula (I) are useful to destroy, inhibit, or prevent the growth or spread of cells, especially malignant cells, into surrounding tissues implicated in a variety of human and animal diseases
摘要:
The present invention relates to a polymorph form of 4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide, and to a process for the preparation thereof.